The Prescription Washington Can’t Fill
The buprenorphine bottleneck in Washington, D.C.’s opioid crisis is not the supply. It is everything standing between the shelf and the person.

The buprenorphine bottleneck in Washington, D.C.’s opioid crisis is not the supply. It is everything standing between the shelf and the person.

Organisms are less like optimized Swiss watches and more like a messy collection of political factions.

COVID and smartphones alone cannot explain the decline. One thing we do know: both young and old need to retain the ability to gather and process information.

Journal prestige shapes what science gets done, how fast it moves, and whose work gets seen. Pushing institutions to engage in open science can make the system more equitable.

The executive branch wants to take control of the scientific enterprise. To stay independent, scientists will need better ways to demonstrate their work’s connection to society’s needs.

Instead of relying on a single act of Congress, U.S. states could implement an evidenced-based, step-by-step sequence that could get the country to single-payer health care coverage.

Incoming lawmakers have an opportunity to build an addiction response that is accountable, effective, and prepared for an evolving public health landscape.

My week with people trying to build a more rigorous framework for international cooperation when the stakes are high and interests diverge.